, kinetic detection with intercalating dyes [28, 29] , several in situ methods [30] [31] [32] , the use of labeled primers [33] , and amplicon capture by probes immobilized on membranes [34, 35] .
Clinical Chemistiy 42:12 1915-1923 (1996) COBAS AMPLICORTM: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR The polymerase chain reaction (PCR) has evolved into one of the most useful methods in molecular biology. 4 Indeed, PCR has revolutionized both the basic and the applied aspects of the biomedical field, with >40 000 papers published involving this technique. PCR has been used for cloning [1] , sequencing [2] , mRNA analysis [3] , DNA and RNA quantification [4] [5] [6] , mutagenesis [7] , gene detection [8] , and identity testing [9-11] and has also been utilized extensively in the field of diagnostics. Viral and bacterial detection, as well as genetic and environmental testing, have all benefited from the use of PCR [JO, [12] [13] [14] [15] [16] [17] [18] [19] .
Since its initial publication in 1985, PCR technology has advanced significantly.
Especially important advances include
the identification and characterization of thermostable DNA polymerases [20, 21] and methods that enhance the specificity of amplification and control contamination [22, 23] . [25] , a homogeneous Taq exonuclease activitybased assay [26, 27] , kinetic detection with intercalating dyes [28, 29] , several in situ methods [30] [31] [32] , the use of labeled primers [33] , and amplicon capture by probes immobilized on membranes [34, 35] .
Although the chemistry improvements have allowed formatting advances in this technology to progress at a fast pace, automation has lagged far behind, particularly for detection
methods.
An exception has been the rapid development of numerous thermal cyclers [36] . Here, we describe a fully automated system for performing routine diagnostic PCR: an integrated system that amplifies DNA targets by PCR or RNA targets by reverse transcription-PCR and then specifically detects the resulting amplification products. This system comprises an amplification subsystem and a detection subsystem. Two running modes are available. In the first mode, used for amplification and detection of 24 or fewer samples, the system automatically initiates detection after amplification is completed (sequential mode); the automated pipettor transfers amplified products for detection from the A-rings in the thermal cycling segments to the D-cups. The second mode is used when testing >24 samples. While a first set of 24 samples is being detected, a second set of the remaining samples is being amplified (parallel mode). The system pauses after amplification of the first set of specimens is complete, allowing the operator to transfer the amplified A-rings to the ambient temperature segments, add additional A-rings to the thermal cycling segments, and restart the system. In this mode, the automated pipettor transfers amplified products for detection from the first set of A-tubes in the ambient temperature segments.
Reagent deliveiy.
All of the reagents required to perform detection are held on the COBAS AMPLICOR system. Stabilized reagents in polyethylene reagent cassettes (maximum capacity 30 mL) are supplied with a piercable cap to minimize evaporation and contamination.
For the COBAS AMPLICOR to monitor reagent availability, each cassette has a label on which the reagent name, lot number, number of aspirations, and expiration date are encoded in alphanumeric and barcode formats. The pipettor is used to transfer an aliquot of reagent from a cassette to either an A-tube or a D-cup. The tip of the pipettor is fabricated to allow easy piercing of the A-tube and reagent cassette caps. The COBAS AMPLICOR automatically rinses the pipettor tip after each reagent transfer. The volume of reagents available on the system is monitored in two ways designed to cross-check and confirm reagent availability. For each reagent, the system tracks the number of aspirations from each cassette and compares this with the number of cassettes loaded on the system. This information is maintained in the system software. In the second method, the system determines the actual volume of reagent that is available in each cassette by electronic sensing of the liquid level.
Photometer The photometer, which measures the absorbance of the detection reaction, contains a pulsed gallium aluminum arsenide (GaAlAs) light-emitting diode with an emission peak of 660 nm operating at a frequency of 35 mHz. The intensity of the pulsed light transmitted through the D-cup is measured by a photomultiplier diode, which produces a current flow proportional to the intensity of transmitted light. The difference between the current flow during each light pulse and the current flow during the following dark period is converted to a digital signal by the analog/digital converter.
EXPERIMENTAL

METHODS
Microfluidics integrity.
Carryover performance of the COBAS AMPLICOR was evaluated with two different reagents, biotinlabeled DNA and horseradish peroxidase (HRP; Boehringer Mannheim, Indianapolis,
The biotin-labeled DNA was generated by amplifying unlabeled DNA on a Perkin-Elmer (Norwalk, CT) GeneAmp#{174} 9600 thermal cycler. The resulting biotin-labeled amplicon was concentrated and purified by ethanol precipitation and quantified by fluorometry and gel analysis. A working solution of HRP was prepared by diluting a stock 10 g/L solution to a concentration 106-fold greater than the concentration required to yield an absorbance of 0.05-0.1 at 660 nm. Samples containing either 3 X l0' copies/mL of amplicon or working HRP solution were interspersed with negative samples: water blanks for DNA tests, and HRP dilution buffer for enzyme tests. Negative samples that were not adjacent to positive samples were used to establish the baseline absorbance of the system. The extent of amplicon and HRP carryover was assessed by measuring the absorbances generated in the interspersed negative samples. [37] . This entire sequence was amplified by the N. Detection is initiated by adding 200 jiL of a working dilution of stabilized avidin-conjugated HRP solution to each D-cup and incubating at 37 #{176}C for 14 mm. Each D-cup is then transferred to the wash station, subjected to a cycle of 4 washes, and returned to the incubator for the final color development step. The third 14-mm, 37 #{176}C incubation is performed in the presence of 300 LL of tetramethylbenzidine (TMB) substrate solution. After this incubation period, the D-cup is transferred to the photometer, where the absorbance is measured. The COBAS AMPLICOR precisely times each step in the hybridization, washing, and detection procedures so that the time interval between initiation of hybridization and measurement of absorbance is the same for each D-cup.
Results
COBAS AMPLICOR TEST FORMAT
The amplification and detection approaches used in the COBAS AMPLICOR system are similar to those in the previously described AMPLICORTI method [24] , with three notable differences:
1) PCR products are captured by hybridization to probecoated paramagnetic microparticles in the COBAS AMPLI-COR format, whereas probe-coated microwell plates are used in the AMPLICOR format.
2) The COBAS AMPLICOR method does not require the use of stop reagent at the end of substrate incubation because the automated system precisely times each step of the hybridization! detection procedure for each test sample.
3) Absorbance readings of the unstopped reactions are measured at 660 nm in the COBAS AiMPLICOR photometer vs readings of stopped reactions at 450 nm in the AMPLICOR format.
As shown in Fig. 2 , PCR is performed by amplifying target nucleic acids in the presence of a thermostable DNA polymerase, AnipErase, dNTPs, and biotinylated primers. After amplification is complete, the resulting amplicons are hybridized to paramagnetic microparticles coated with a test-specific deoxyribonucleotide probe [38J. At the conclusion of hybridization, the reaction mixture is separated magnetically, the unincorporated primers and dNTPs are aspirated, and the microparticles remaining are washed. Detection is accomplished by incubating the microparticles with avidin-HRP conjugate and reacting with TMB substrate. The resulting colorimetric product is read at 660 nm by the on-board photometer. As each specimen reading is completed, results are automatically transmitted to a printer or host computer through a laboratory information system interface. The COBAS ArVIPLICOR compares each absorbance value with an established, assay-specific cutoff and reports the test result as positive, negative, or grey zone, along with the actual absorbance value, For the currently available tests, the cutoffs for negative specimens range from 0.2 to 0.35 A660, and the cutoffs for positive specimens range from 0.2 to 0.8 A660.
The grey zone is defined as the interval between the negative and positive cutoffs; some of the tests do not have a grey zone.
SYSTEM WASH EFFICIENCY
One of the challenges of the automated system is to pipette highly concentrated amplicon and reagent mixtures without carryingover DNA or reagents to successive pipetting steps.
The system must also provide for stringent washing of the microparticles to avoid false-positive signals caused by nonspecific binding of reagents. Evaluation of amplicon carryover was performed by manually adding a highly concentrated amplicon solution (3 x 1013 copies/100 L) into an A-tube in an A-ring. The flanking A-tubes contained water. The COBAS AMPLICOR was programed to transfer aliquots from the three A-tubes to D-cups in the order: water, amplicon, water; five successive aliquots were transferred from the second water tube. The aliquot from the first water tube served as the negative control. To provide a reference for quantifying small amounts of carryover, three D-cups containing 3 X 10#{176} amplicon copies/l00 L (i.e., a l:10 dilution of the concentrated amplicon solution) were included in each run. A standard detection assay was performed as described in Materials and Methods. A-tubes were filled wIth waterorconcentrated amplicon (3 X iO' copies/mL) and the COBAS AMPLICOR was programed to transfer aliquots from the three A-tubes to 0-cups in the order water, amplicon, water; multiple aliquots were transferred from the second water tube and analyzed for amplicon with use of 50 pg of coated microparticles per assay. reference, we added a 1:106 dilution of the concentrated HRP solution to D-cups manually, and the COBAS AMPLICOR added the TMB substrate solution. After TMB substrate was added, the D-cups were incubated for 14 mm at 37 #{176}C and their absorbances were read by the photometer. The results (Fig. 4) demonstrate that two pipette rinsings and one intermediate transfer step reduced the HRP concentration by at least 106-fold in all 10 systems.
Dl 0e4 dil'n of
The combined wash efficiency of the pipette and wash station modules was evaluated by performing complete detection runs in the absence of amplicon. on each of seven instruments and performing single runs on an additional three instruments. An amplicon corresponding to a region in the C. trachomatis cryptic plasmid was used as the target sequence [24] . Purified amplicon was diluted to a concentration corresponding to an absorbance of 1.0 on a "standard" instrument for all experiments. As shown in Fig. 6 , intrainstrument precision (CV) ranged from 2.5% (instrument 6) to 4.1% (instrument 5). The instrument mean absorbance values ranged from 0.910 to 1.064 for the 20 runs (data not shown).
Combined amplification and detection precision was evaluated by performing PCR amplification in the thermal cycler module and detection in the detection subsystem. A cloned region of the C. trachomatis cryptic plasmid was used as the target template. Amplification reagents and procedures were as described [24] , except that the number of amplification cycles was reduced. This modification was required to generate signals in the linear range of the spectrophotometer. Each PCR reaction contained 20 input copies of target plasmid. Fig. 7 compares the intrainstrument precision for the 10 systems investigated; CVs ranged between 9.5% and 20%. A portion of this variation was attributed to statistically expected fluctuation in the amount of the input target DNA. For an average of 20 DNA copies added to each reaction, the SD would be 4. strated that the CV was reduced from 17.8% to 9.3% when the input target DNA concentration was increased from an average of 10 (± 3.2, 63% variation) to 100 (± 10, 20% variation) input target copies per amplification reaction.
DETECTION OF MULTIPLE TARGETS FROM A SINGLE
AMPLIFICATION
The COBAS AMPLICOR format is designed to easily detect multiple targets from a single amplification reaction. To demonstrate this capability, we used the instrument to simultaneously amplify three unique target DNAS in single reactions. The third DNA target, a cloned segment of N. gonorrhoeae DNA, contained a completely different sequence and was amplified with a second pair of primers that had been included in the amplification reaction mixture. The products of each amplification reaction were tested in three separate detection reactions. Each detection reaction utilized probe-coated paramagnetic particles specific for one of the three amplification products. A PCR reaction mixture containing primer pairs for both targets was added to a series of six A-tubes. Target DNAS were then added individually and in various combinations. The concentration of each target was 20 copies per reaction. The COBAS AMPLICOR was programed to amplify the samples and then perform three detections for each reaction. Amplification reactions containing only one target DNA generated a positive signal only with the corresponding probe-coated paramagnetic particles (Fig. 8) . This demonstrates that the probecoated paramagnetic particles react specifically with their respective target sequences. For reactions containing more than one target, the signals generated for each of the probes corresponded to the combination of targets tested (Fig. 8) . Furthermore, each of these signals was equivalent to that obtained when only one target was present (Fig. 8) . Thus, the multiple targets were simultaneously and independently amplified. Collectively, these observations demonstrate that the COBAS AMPLICOR format can simultaneously amplify multiple targets and distinguish between the resulting sets of amplification products.
Discussion
In this fully automated system for PCR amplification and detection, the instrument automates three processes: PCR amplification of target nucleic acid obtained from a sample, capture hybridization of the amplified products to oligonucleotide probes specific for the target, and detection of the probe-bound amplified products by enzyme-mediated formation of color that can be quantified spectrophotometrically.
A total of 48 samples may be handled concurrently, and amplification and detection can be performed simultaneously by the system. Instrument run modes are flexible. The instrument can be programed to perform amplification and detection reactions in sequential or parallel modes. The sequential mode provides complete walkaway capability; once the system is started, results are generated without operator intervention.
In the parallel mode, the operator loads the first set of samples on the instrument.
At any convenient time after amplification is completed, the operator briefly returns to the instrument to transfer the amplified samples to the ambient temperature holding blocks and load a second set of samples into the thermal cycler. The second set of samples is amplified while the amplification products of the first set are being detected. Results for both sets of samples are generated without further operator intervention.
The system combines five instruments (thermal cycler, incubator, wash station, pipettor, and photometer) into a single unit. The system can simultaneously perform multiple assays because the thermal cycler module contains two segments that allow two different amplification profiles to run concurrently. In the parallel mode, up to four different amplifications profiles can be performed (two profiles in each of the two amplification runs). When performing multiple assays, the user programs the system to detect products from each amplification reaction by using the appropriate capture probe.
The system can also perform multiplex assays, in which multiple targets are detected after a single amplification of a specimen. Multiplex testing is possible when the amplification reaction contains multiple sets of primer pairs, each specific for a particular target. In the multiplex testing mode, the user programs the system to perform multiple, unique detections for each amplification reaction. The ability to automatically perform multiple detections for a single amplification reaction also gives the operator the option of using the Internal Control to identify specimens containing substances that interfere with PCR amplification.
The Internal
Control is a DNA plasmid, or its complementary RNA transcript, that contains primer-binding regions identical to those in the specific target nucleic acid and a unique probe-binding region whereby it is distinguished from the target nucleic acid. The Internal Control is coamplified with target nucleic acid in the specimen and detected after capture by paramagnetic particles coated with an Internal Control-specific probe. In specimens that are negative for target nucleic acid, a positive signal for the Internal Control provides assurance that the specimen was successfully amplified and detected.
The system's internal software provides reflex testing capability to maximize throughput and minimize unnecessary testing. Using this feature, the operator preprograms the instru-ment to automatically perform additional detections on amplified samples on the basis of the initial detection results. For example, instead of performing an Internal Control detection for every sample being tested, the instrument can be programed to perform detection for the specific target first and then perform the Internal Control detection only for those specimens giving negative results.
Our investigation of the washing capabilities of the instrument and of overall system performance found no evidence of amplicon or reagent carryover. Thus, the pipetting module design and associated pipette tip-rinsing procedure effectively removes residual DNA and other reagents from the pipette tip after each pipetting step. Overall wash-efficiency studies of the COBAS AMPLICOR detection format showed that, under standard assay conditions, the microparticles and the detection cups are thoroughly washed. Results from the detection precision studies demonstrate excellent reproducibility (CVs of 3-4%) of the COBAS AMPLICOR detection subsystem; in comparison, the AMPLICOR microwell plate detection format Because we have demonstrated that CVs are a function of target input, systems must be tested with the same target copy number for CVs to provide an indication of comparative reproducibility.
In conclusion, nucleic acid amplification technologies have the potential to revolutionize diagnostic testing. These techniques must, however, be simplified and automated for routine use in the clinical diagnostic laboratory. Commercially available kits, such as the AMPLICOR series of PCR tests, have greatly simplified amplification technology, enabling it to be adopted by clinical laboratories that have limited molecular biology expertise. The COBAS AMPLICOR system, with commercially available test kits, represents the next-generation improvement by automating the entire amplification and detection procedure. This system simplifies laboratory set up, consolidates steps and workstations, and decreases hands-on labor. It also permits one laboratory to perform multiple assays with a common platform and format. The initial COBAS AMPLICOR menu includes qualitative tests for diagnosing C. rachomatis, N. gonorrhoeae, M.
tuberculosis, and hepatitis C virus infections. Quantitative CO-BAS AMPLICOR tests for human immunodeficiency virus, hepatitis C virus, and human cytomegalovirus are now being developed. Such automated, quantitative tests will substantially expand the utility of PCR by allowing its routine use for disease prognosis and monitoring drug therapy.
